AzTrials
AzTrials

ObesityACTION ChinaNCT05428501

Awareness, Care & Treatment In Obesity Management - An Observation in Mainland China

An observational study of Obesity, run by Novo Nordisk A/S at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

ACTION China is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Obesity
What is being tested?
no treatment given
How many people
8,000 participants
Where
1 siteChina
Study dates
18 Aug 2022to 30 Nov 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: The respondent population will include people living with obesity (PLwO) and health care professionals (HCPs) involved in obesity treatment and management

Who may be able to join

  • PLwO:
  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, aged above or equal to 18 years at the time of signing informed consent
  • Lives in mainland China and is native Chinese
  • Current BMI based on self-reported height and weight of at least 28 kg/m^2 as per mainland China definition of obesity(16) (calculated using an algorithm within the survey instrument)
  • HCPs:
Show all 14Show fewer
  • Informed consent obtained before any study related activities (study-related activities are any procedure related to recording/collection of data according to the protocol)
  • Male or female, aged greather than or equal to18 years at the time of signing informed consent.
  • Physician with a license to practice
  • Specialty is not surgeon (including general, bariatric or plastic surgeon)
  • Practices in mainland China with at least 5 years in clinical practice
  • Spends at least 50% of time in direct patient care (as opposed to surgical procedures, office procedures or research/administrative tasks)
  • Has seen at least 100 patients in the past month
  • Has seen at least 10 patients needing weight management (defined as a patient with a BMI greather than or equal to28 kg/m^2 with or without comorbidities) in the past month

Who cannot join

  • PLwO
  • 1. Previous participation in this study. Participation is defined as having given online consent in this study 2. Currently pregnant 3. Participates in intense fitness or body building programs 4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months 5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation HCPs
  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Unwillingness, inability, or language barriers precluding adequate understanding or cooperation

Trial locations and contacts

1 site in 1 country.

China1 site

  • Novo Nordisk Investigational Site

    Beijing

Other trials in China

About this study

ACTION China is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor.

The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Conditions
Obesity
Being tested
no treatment given
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • no treatment givenOther

    People / Person Living with Obesity (PLwO) Health Care Professionals (HCPs)

Study groups in NCT05428501
Study groupRoleWhat they receive
Person Living with Obesity (PLwO)PLwO recruited via online platforms or face-to-face channels
Receives: Other: no treatment given
Health Care Professionals (HCPs)HCPs treating people who have obesity
Receives: Other: no treatment given

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight loss motivators

    Multi-selection from defined list

    Measured: Day 1-day of survey

  2. PLwO / participants who made serious weight loss effort

    Percentage of participants

    Measured: Day 1-day of survey

  3. Response to/evaluation of weight loss discussion according to predefined list of values

    Single selection from defined list

    1. Not at all helpful
    2. A little helpful
    3. Somewhat helpful
    4. Very helpful
    5. Extremely helpful

    Measured: Day 1-day of survey

  4. Effective weight loss methods

    Multi-selection from defined list

    Measured: Day 1-day of survey

  5. Obesity attitudes

    5-point Likert scales:

    1: Do not agree at all 5: Completely agree

    Measured: Day 1-day of survey

  6. Attitudes toward prescription weight loss medication and surgery

    5-point Likert scales:

    1: Do not agree at all 5: Completely agree

    Measured: Day 1-day of survey

  7. Agreement with predefined Obesity and weight management measures

    5-point Likert scales:

    1: Do not agree at all 5: Completely agree

    Measured: Day 1-day of survey

  8. Degree to which healthcare and society is meeting needs of PLwO

    5-point Likert scales:

    1: Not at all meeting the needs 5: Completely meeting the needs

    Measured: Day 1-day of survey

Secondary outcomes (8)

  1. Weight loss barriers

    Multi-selection from defined list

    Measured: Day 1-day of survey

  2. Top factors for improving weight loss outcomes

    Multi-selection from defined list

    Measured: Day 1-day of survey

  3. Types of weight management goals

    Multi-selection from defined list

    Measured: Day 1-day of survey

  4. Most helpful information for participants for weight loss

    Multi-selection from defined list

    Measured: Day 1-day of survey

  5. Responsibility for improving health of PLwO (rank of individuals/organizations in order of their responsibility)

    Rank of multi-selection from defined list of individuals/organizations in order of their responsibility.

    Ranks 1 - 3 where "1" means most responsible and "3" means least responsible

    Measured: Day 1-day of survey

  6. Most helpful support for weight loss

    Multi-selection from defined list

    Measured: Day 1-day of survey

  7. Effectiveness of guidelines for treating obesity

    5-point Likert scales:

    1. Not at all effective
    2. A little effective
    3. Somewhat effective
    4. Very effective
    5. Extremely effective

    Measured: Day 1-day of survey

  8. Ways participants receive information on weight loss management

    Multi-selection from defined list

    Measured: Day 1-day of survey

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2022
  2. Study start18 Aug 2022
  3. Primary completion30 Nov 2022
  4. Study completion30 Nov 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
8,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05428501
Sponsor's protocol ID
DAS-004
Other IDs
U1111-1266-4279
Acronym
ACTION China
Status last verified
Sep 2024
First submitted
19 May 2022
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: According to the Novo Nordisk disclosure commitment on novonordisk-trials.com

Publications

  • Ji L, Mu Y, Chang C, Wang H, Zhao D, Liu D, Shen Z, Chen W. Perceptions, attitudes and barriers to effective obesity care among people living with obesity and healthcare professionals in China: The ACTION-China study. Diabetes Obes Metab. 2024 Oct;26(10):4694-4704. doi: 10.1111/dom.15837. Epub 2024 Aug 9.

    PubMed 39119627

  • Luo Y, Mu Y, Chen W, Wang H, Zhao D, Liu D, Zhang J, Ji L. Attitudes towards therapeutic options for weight management, including weight loss medications and surgery, among people living with obesity and healthcare professionals in China: A secondary analysis from the ACTION-China study. Diabetes Obes Metab. 2025 Jul;27(7):3627-3634. doi: 10.1111/dom.16369. Epub 2025 Apr 15.

    PubMed 40230237

Questions about this trial

What is this clinical trial studying?

An observational study of Obesity, run by Novo Nordisk A/S at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight loss motivators (time frame: Day 1-day of survey). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05428501, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024; AzTrials last refreshed its copy on 8 Nov 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in